DNLI's BLA for Hunter Syndrome Drug Gets FDA's Priority Review

• click to rate

  Posted by Two Blokes Jul 8 - Filed in Stock - 5 views
  
  Denali's lead drug for Hunter syndrome wins FDA Priority Review, marking a key step toward commercial-stage status.